Combined immunochemotherapy achieving targeted co-delivery of chlorogenic acid and doxorubicin by sialic acid-modified liposomes enhances anti-cancer efficacy.

[1]  L. Sapio,et al.  Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells , 2021, International journal of molecular sciences.

[2]  H. Santos,et al.  Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy. , 2020, Acta biomaterialia.

[3]  Yan-fang Yang,et al.  Construction of chlorogenic acid-containing liposomes with prolonged antitumor immunity based on T cell regulation , 2020, Science China Life Sciences.

[4]  Yan-fang Yang,et al.  Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma , 2020, Bioactive materials.

[5]  E. Gazzano,et al.  Overcoming Doxorubicin Resistance with Lipid-Polymer Hybrid Nanoparticles Photoreleasing Nitric Oxide. , 2020, Molecular pharmaceutics.

[6]  F. Guan,et al.  Biological Functions and Analytical Strategies of Sialic Acids in Tumor , 2020, Cells.

[7]  V. Chekhun,et al.  Macrophages - a perspective target for antineoplastic immunotherapy. , 2019, Experimental oncology.

[8]  Wei-Zen Sun,et al.  BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes , 2019, Journal of Immunotherapy for Cancer.

[9]  R. Carvajal,et al.  Novel Targets for the Treatment of Melanoma , 2019, Current Oncology Reports.

[10]  Ying Wang,et al.  Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[11]  Robert J. Lee,et al.  Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma , 2019, Molecules.

[12]  P. Spellman,et al.  Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets , 2019, Cancer cell.

[13]  Jian-qiu Lu,et al.  Profiling and identification of chlorogenic acid metabolites in rats by ultra-high-performance liquid chromatography coupled with linear ion trap-Orbitrap mass spectrometer , 2018, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  Michael F. Cuccarese,et al.  TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy , 2018, Nature Biomedical Engineering.

[15]  C. Luo,et al.  Research progress in advanced melanoma. , 2017, Cancer letters.

[16]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[17]  Qin Zhou,et al.  Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype , 2017, Scientific Reports.

[18]  A. D. de Vos,et al.  Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages. , 2016, Cell reports.

[19]  G. Adema,et al.  Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis. , 2016, Trends in biochemical sciences.

[20]  V. Gotlieb,et al.  The rapidly evolving therapies for advanced melanoma--Towards immunotherapy, molecular targeted therapy, and beyond. , 2016, Critical reviews in oncology/hematology.

[21]  D. Mcclements.  Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems. , 2015, Advances in colloid and interface science.

[22]  J. M. Marchetti,et al.  Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. , 2014, Colloids and surfaces. B, Biointerfaces.

[23]  Yanzhi Song,et al.  The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate. , 2014, Biomaterials.

[24]  Jens Pietzsch,et al.  Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages. , 2014, Biochemical and biophysical research communications.

[25]  D. Colangelo,et al.  pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[26]  C. Drake.  Combination immunotherapy approaches. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  H. Crijns,et al.  Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. , 2012, Journal of molecular and cellular cardiology.

[28]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[29]  Li Zhang,et al.  Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy? , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[30]  K. Edwards,et al.  Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[31]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[32]  Liang Wenhua,et al.  Chlorogenic acid (CGA): A pharmacological review and call for further research. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  J. Gershenwald,et al.  Stemming the Rising Incidence of Melanoma: Calling Prevention to Action. , 2016, Journal of the National Cancer Institute.